Vascular endothelial growth factor and related molecules in acute lung injury

被引:142
作者
Mura, M
dos Santos, CC
Stewart, D
Liu, MY
机构
[1] Univ Hlth Network, Thorac Surg Res Labs, Toronto Gen Res Inst, Toronto, ON M5G 2C4, Canada
[2] St Michaels Hosp, Dept Crit Care Med, Toronto, ON M5B 1W8, Canada
[3] St Michaels Hosp, Dept Cardiol, Toronto, ON M5B 1W8, Canada
[4] St Michaels Hosp, Div Mol & Cell Biol Res, Toronto, ON M5B 1W8, Canada
[5] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON M5S 1A8, Canada
关键词
acute respiratory distress syndrome; pulmonary edema; angiopoietins; hypoxia; hyperoxia;
D O I
10.1152/japplphysiol.00202.2004
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
VEGFs and their receptors have been implicated in the regulation of vascular permeability in many organ systems, including the lung. Increased permeability and interstitial and pulmonary edema are prominent features of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Extrapolating data from other organ systems and animal experiments have suggested that overexpression of VEGF functions primarily as proinjurious molecules in the lung. Recent data, from animal models as well as from patients with ARDS, have shown decreased levels of VEGF in the lung. The role of VEGF and related molecules in ALI/ARDS is, therefore, controversial: what has become clear is that there are many unique features in the regulation of pulmonary vascular permeability and in VEGF expression in the lung. In this review, we explore a growing body of literature looking at the expression and function of VEGF and related molecules in different models of ALI and in patients with ALI/ARDS. Novel evidence points to a potential role of VEGF in promoting repair of the alveolar-capillary membrane during recovery from ALI/ARDS. Understanding the role of VEGF in this disease process is crucial for developing new therapeutic strategies for ALI/ARDS.
引用
收藏
页码:1605 / 1617
页数:13
相关论文
共 147 条
[111]   VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses [J].
Rissanen, TT ;
Markkanen, JE ;
Gruchala, M ;
Heikura, T ;
Puranen, A ;
Kettunen, MI ;
Kholová, I ;
Kauppinen, RA ;
Achen, MG ;
Stacker, SA ;
Alitalo, K ;
Ylä-Herttuala, S .
CIRCULATION RESEARCH, 2003, 92 (10) :1098-1106
[112]  
ROBERTS WG, 1995, J CELL SCI, V108, P2369
[113]  
Robinson CJ, 2001, J CELL SCI, V114, P853
[114]  
Roche J, 2002, ADV EXP MED BIOL, V515, P103
[115]   Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes [J].
Saaristo, A ;
Veikkola, T ;
Enholm, B ;
Hytönen, M ;
Arola, J ;
Pajusola, K ;
Turunen, P ;
Jeltsch, M ;
Karkkainen, MJ ;
Kerjaschki, D ;
Bueler, H ;
Ylä-Herttuala, S ;
Alitalo, K .
FASEB JOURNAL, 2002, 16 (09) :1041-1049
[116]  
Satchell SC, 2001, THROMB HAEMOSTASIS, V86, P1597
[117]   Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain [J].
Schoch, HJ ;
Fischer, S ;
Marti, HH .
BRAIN, 2002, 125 :2549-2557
[118]  
SEETHARAM L, 1995, ONCOGENE, V10, P135
[119]  
Semenza GL, 2000, ADV EXP MED BIOL, V475, P123
[120]   FAILURE OF BLOOD-ISLAND FORMATION AND VASCULOGENESIS IN FLK-1-DEFICIENT MICE [J].
SHALABY, F ;
ROSSANT, J ;
YAMAGUCHI, TP ;
GERTSENSTEIN, M ;
WU, XF ;
BREITMAN, ML ;
SCHUH, AC .
NATURE, 1995, 376 (6535) :62-66